TrialMolecular genetics and metabolism2011

An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay-Sachs or Sandhoff variants).

Joe T R Clarke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.